13Nov
Covid–19 coronavirus: global merger review (updated 13 November 2020)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
In today’s edition of Daily Compliance News: • Another guilty verdict in FCPA trial. (WSJ) • Sams...
Read More >
Financial Institutions M&A sector trends: Specialty finance/marketplace Lending — H1 2020 and outlo...
Read More >
A recent decision of the North Carolina Court of Appeals serves as an important reminder to avoid th...
Read More >
Design-build contracts (and their lesser utilized counterpart—engineering, procurement, and constru...
Read More >
Q: Are there any new cases involving Pennsylvania’s Medical Marijuana Act in the context of employm...
Read More >
Employers continuously face a key employee or consultant leaving or separating from the company to j...
Read More >